Parcourir par auteur "Hezode, Christophe"
Résultats 1-7 de 7
-
Absence of impact of direct acting antivirals for hepatitis c virus on recurrent hepatocellular carcinoma tumor growth in the afef/anrs co22 hepather cohort
Vallet-Pichard, Anais; Correas, Jean-Michel; Dorival, Celine; et al.Clinics and Research in Hepatology and Gastroenterology, 25-06-2020Article dans une revue scientifique -
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Carrat, Fabrice; Fontaine, Helene; Dorival, Celine; et al.The Lancet, 06-04-2019, 393, 1453-1464Article dans une revue scientifiquetexte intégral -
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes.
Cacoub, Patrice; Bourliere, Marc; Asselah, Tarik; et al.Value in Health, 10-2018, 21, 1218-1225Article dans une revue scientifique -
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Bourliere, Marc; Bronowicki, Jean-Pierre; De Ledinghen, Victor; et al.The Lancet. Infectious diseases, 01-04-2015, 15, 397-404Article dans une revue scientifique -
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
Pol, Stanislas; Bourliere, Marc; Lucier, Sandy; et al.Journal of hepatology, 01-01-2017, 66, 39-47Article dans une revue scientifique -
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
Laurain, Anne; Metivier, Sophie; Haour, Georges; et al.BMC Infectious Diseases, 02-04-2019, 19, 300Article dans une revue scientifique -
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Feld Jordan, J; Jacobson Ira, M; Hezode, Christophe; et al.The New England journal of medicine, 31-12-2015, 373, 2599-2607Article dans une revue scientifique